Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-990 Cr₹-856 Cr₹-288 Cr₹122 Cr₹122 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA is ₹-990 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-990 Cr
Mar2024₹-856 Cr
Mar2023₹-288 Cr
Mar2022₹122 Cr
Mar2021₹122 Cr

How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-990 Cr
Negative
Mar2024 ₹-856 Cr
Negative
Mar2023 ₹-288 Cr
Negative
Mar2022 ₹122 Cr
0.40
Mar2021 ₹122 Cr -

Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,536.4 Cr -2.3% -6.4% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,147.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹161,208.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,190.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹110,790.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,587.0 Cr 3.5% -5.2% -11.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.3%

-6.4%

-4.8%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses